Hello Patient vs Hyro (2026)
If your failure mode is choosing the newest and most autonomous agent for an enterprise rollout without the track record or architectural visibility a large system needs, this pair frames the tradeoff. Hyro has built for healthcare since 2018 and offers the clearest architecture in the lane, a hybrid of large language models, a proprietary conversational engine, small healthcare tuned models, and knowledge graphs, deployed across 45 to 50 health systems with an investing client and direct API into Epic that completes tasks rather than routing them. Hello Patient, founded in 2024, is the more autonomous and faster to stand up, targeting a 100 percent answer rate across the front office, but with roughly a year of reported volume and no published escalation threshold. Enterprise depth and interrogable architecture, or a newer, more autonomous, quicker build.
- More autonomous across the full front office loop, inbound and outbound, with practices reported moving from 20 to 30 percent unanswered calls to zero, if maximal call coverage is the immediate goal.
- Candid about its stack and quick to deploy: it states it fine tunes existing models rather than claiming its own, names its voice partner, and publishes SOC 2 Type 2 and HIPAA directly.
- Broad across outpatient specialties including smaller settings that premium enterprise platforms tend not to prioritize.
- The clearest architecture in the lane and the transparency a large system's review needs: a documented hybrid of LLMs, a conversational engine, small healthcare tuned models, and knowledge graphs that constrain what the agent can assert.
- Enterprise proven: 45 to 50 US health systems, more than 30 million patients, named clients including Intermountain and Baptist, Bon Secours invested as a client, and a 2026 Fierce 15 selection, against a competitor founded in 2024.
- Completes the transaction through direct API into Epic and CRMs rather than routing it, the capability that separates this tier from IVR replacement.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Hello Patient and Hyro are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Hello Patient | Hyro |
|---|---|---|
| Primary category | Patient Voice Agents | Patient Voice Agents |
| Founded | 2024 | 2018 |
| Headquarters | Austin, Texas, United States | New York, New York |
| Website | hellopatient.com | hyro.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Hello Patient its top capability grade on AI Centrality. Set against Hyro, Hello Patient grades higher on Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Hyro its top capability grade on AI Centrality, Model and Technology Transparency and EHR and Interoperability Depth. Set against Hello Patient, Hyro grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Hello Patient or Hyro?
On the axes where the AI Health Index separates them, Hello Patient grades higher on Security Certifications and Trust Center, and Hyro grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Clinical and Operational Evidence. Hyro leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Hello Patient and Hyro differ most?
The widest separation the AI Health Index records between Hello Patient and Hyro is on Security Certifications and Trust Center, where Hello Patient grades B and Hyro grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Hello Patient and Hyro grade the same?
The AI Health Index grades Hello Patient and Hyro the same on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Patient Voice Agents page.
Both are vendor reported on their operational headlines and both leave the escalation trigger unpublished, the boundary that matters most for refill and triage adjacent requests; Hello Patient is graded a step lower on oversight, at C, for pairing a 100 percent answer target with no disclosed human handoff, while Hyro discloses that transfer exists but not when it fires. Hello Patient, founded in 2024, has no longitudinal track record; Hyro's adoption is independently corroborated.
Neither publishes pricing, and Hyro is explicitly premium tier, with smaller practices often served by more accessible alternatives, a group Hello Patient targets. Hello Patient carries graded SOC 2 Type 2 and HIPAA in this index; Hyro's record does not, so confirm directly. Voice accuracy varies across accent and dialect.